Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients.

Aghamohammadi, Mehdi; Alizargar, Javad; Hsieh, Nan-Chen; Wu, Shu-Fang Vivienne

Aghamohammadi, Mehdi; Alizargar, Javad; Hsieh, Nan-Chen; Wu, Shu-Fang Vivienne.

Afiliação

Aghamohammadi M; Department of Internal Medicine, Vali-e-asr Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Alizargar J; Research Center for Healthcare Industry Innovation, National Taipei University of Nursing and Health Sciences, Taipei City, 112, Taiwan. Electronic address: jaz.tmu@gmail.com.
Hsieh NC; Department of Information Management, National Taipei University of Nursing and Health Sciences, Taipei City, 112, Taiwan.
Wu SV; College of Nursing, School of Nursing, National Taipei University of Nursing and Health Sciences, Taipei City, 112, Taiwan.

J Formos Med Assoc ; 119(7): 1230-1231, 2020 07.

Article em En | MEDLINE | ID: mdl-32402522

Assuntos

Anticoagulantes; Infecções por Coronavirus; Pandemias; Pneumonia Viral; Acidente Vascular Cerebral; Betacoronavirus; COVID-19; Humanos; Itália; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Acidente Vascular Cerebral / Pandemias / Anticoagulantes Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Formos Med Assoc Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google